Powered by Microsoft’s advanced cloud and AI technologies, the platform brings together AI agents to reduce administrative burden and give clinicians more time to focus on patients.
Abu Dhabi, United Arab Emirates. October 22, 2026: M42, a global health leader powered by artificial intelligence (AI), technology, and genomics, today announced the launch of Ossi, its next-generation multi-agent AI Clinical Platform, during the Abu Dhabi Future Health Summit. Built on Microsoft Azure’s secure cloud & AI infrastructure, Ossi is designed to create a seamless balance between clinical precision and human connection by reducing administrative burden, deepening client-patient connections, and enhancing use of data and evidence-based guidelines at point of care data-driven through secure, ambient intelligence.
Designed to ease the burden of clinical documentation and enable more time for clinician–patient interaction, Ossi has been activated across seven of M42 healthcare facilities in the UAE and Bahrain including Amana UAE, Amana Bahrain, Healthpoint, HealthPlus, Mubadala Health Dubai, Sheikh Sultan bin Zayed Hospital, and Imperial College London Diabetes Centre in Abu Dhabi.
The name Ossi, inspired by the ossicle bone in the human ear, symbolizes the platform’s ability to listen with precision and capture clinician information effortlessly. Much like the ossicles amplify and refine sound, Ossi supports clinicians by amplifying the clinical context with previous medical data and evidence based clinical guidelines, all this while ensuring alignment with the required standards of patient information security and data privacy. Ossi transforms the clinical experience by enabling clinicians to focus on their patients and their care thereby enabling meaningful patient doctor-patient engagement without distractions of documentation. This is a big win for both patients and clinicians.
Built on M42’s proprietary architecture and powered by Microsoft Azure AI infrastructure, Ossi will launch with four agents, the first in an expanding suite of capabilities designed to support clinicians across their workflows:
- Ambient Scribe Agent: Transcribes clinical conversations and prepares draft documentation for clinician review.
- Health Record Agent: Retrieves and summarizes relevant information from electronic medical records (EMRs), helping clinicians review patient context.
- Clinical Q&A Agent: Helps clinicians access relevant clinical information and prepare patient-friendly educational content.
- Coding Agent: Suggests medical codes based on clinical documentation for review by the appropriate teams.
The platform is LLM model-agnostic, multilingual, and seamlessly integrates with existing electronic medical record systems via Health Level Seven (HL7) and Fast Healthcare Interoperability Resources (FHIR) standards or custom APIs.
Dimitris Moulavasilis, Group Chief Executive Officer at M42, said: “With Ossi, we are not just introducing new technology; we are introducing a new way of practicing medicine. This is a defining moment in our journey to transform global healthcare. At M42, we believe the future of care lies in intelligent systems that anticipate needs, remove friction, and elevate the human experience. By embedding advanced AI into the heart of clinical workflows, we’re improving documentation, while enabling a shift toward truly predictive, personalized, and proactive care that puts the clinician and patient experience at the center.”
Kareem Shahin, CEO, Digital Health Solutions Platform and Group Chief Digital Officer, M42, said: “Ossi represents a leap forward in clinical transformation. By integrating LLMs in a secure and compliant manner with speech recognition and natural language processing, we’re creating a seamless interface between clinicians and data. The platform’s ability to auto-generate structured notes, adapt to multilingual inputs, and synchronize with EMRs in real time represents a scalable solution to one of the industry’s most complex workflow challenges.”
Elena Bonfiglioli, Global Business Leader VP Healthcare, Pharma and Life Sciences at Microsoft said: “Ossi represents an important milestone in our ongoing collaboration with M42. Microsoft Azure provides a trusted foundation for Ossi to streamline clinicians’ workflow and enhance patient care. Microsoft is committed to empowering the healthcare industry with secure, scalable, and innovative cloud solutions. We are proud to empower M42 as they enable a new way of delivering care and reduce administrative burden.”
In collaboration with Microsoft, M42 has ensured Ossi meets the world’s most stringent health data security and privacy standards. It supports enterprise-level compliance with regional data governance regulations, including those in the UAE.
-Ends-
About M42
M42 is a global health leader powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver predictive, preventive and personalized care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2023, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 27 countries and over 20,000 employees. M42 includes renowned healthcare providers including Danat Al Emarat, Diaverum, Imperial College London Diabetes & Endocrine Centre (ICLDEC), Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi, Abu Dhabi’s health information exchange.
About Future Health – A Global Initiative by Abu Dhabi
Future Health is a year-round platform for global collaboration and transformative health innovation, held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council.
Bringing together health researchers, policymakers, business leaders, investors and entrepreneurs from across disciplines and geographies, Future Health drives collective action to strengthen health systems and unlock longer, healthier lives for all.
Through a year-round programme of research insights, publications, impact initiatives, Challenges, R&D funding, and cross-sector convenings, Future Health advances progress across four focus areas: longevity and precision medicine, health systems and sustainability, digital health and AI, and investment in life sciences.
Future Health is curated and convened by the Department of Health – Abu Dhabi and its Founding Partners: PureHealth, M42, Institute for Healthier Living Abu Dhabi, and Mubadala Bio. Mediclinic Middle East serves as Strategic Partner and Burjeel Holdings as Associate Partner.
For more information, visit http://www.futurehealthinitiative.ae and follow Future Health on: X, Instagram, LinkedIn and Facebook.
For media inquiries, please contact [email protected]
